Literature DB >> 10423345

Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism.

W K Jones1, M P Flaherty, X L Tang, H Takano, Y Qiu, S Banerjee, T Smith, R Bolli.   

Abstract

Recent studies implicate iNOS as the mediator of the late phase of ischemic preconditioning (PC). However, it is unknown whether induction of iNOS activity is mediated by transcriptional, post-transcriptional, translational, or post-translational mechanisms. To address this issue, we isolated and sequenced a partial iNOS cDNA expressed in preconditioned rabbit myocardium. Using a rabbit-specific probe generated from this sequence, we measured the steady state levels of the iNOS transcript after ischemic PC [six cycles of 4-min occlusion/4-min reperfusion (O/R)]. Three hours after ischemic PC, the iNOS mRNA levels in the ischemic/reperfused region were increased approximately three-fold relative to samples from the non-ischemic region and from control rabbits. This increase in mRNA levels was completely abolished by pretreatment with the NOS inhibitor Nomega -nitro- L-arginine. Conversely, administration of the NO donor nitroglycerin induced an increase in iNOS mRNA levels similar to that induced by ischemic PC. We conclude that in the conscious rabbit, ischemic PC induces an increase in iNOS mRNA levels, and that this induction is triggered by increased generation of NO during the PC stimulus. These results provide direct evidence that upregulation of iNOS is a natural response of the heart to a brief ischemic stress and that NO itself, in the absence of ischemia, upregulates myocardial iNOS transcript levels, a finding that may have implications for nitrate therapy. This previously unrecognized NO-dependent upregulation of iNOS mRNA is likely to play an important role in the development of late PC as well as in many other pathophysiological conditions in which NO is implicated. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423345     DOI: 10.1006/jmcc.1999.0983

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  13 in total

Review 1.  Nitrite as a mediator of ischemic preconditioning and cytoprotection.

Authors:  Daniel Murillo; Christelle Kamga; Li Mo; Sruti Shiva
Journal:  Nitric Oxide       Date:  2011-01-26       Impact factor: 4.427

Review 2.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

3.  NF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning.

Authors:  Michael Tranter; Xiaoping Ren; Tiffany Forde; Michael E Wilhide; Jing Chen; Maureen A Sartor; Mario Medvedovic; W Keith Jones
Journal:  J Mol Cell Cardiol       Date:  2010-07-16       Impact factor: 5.000

4.  Comparison of various methods of vessel ligation: what is the safest method?

Authors:  Chang-Sup Lim; Jin-Young Jang; Seung Eun Lee; You Jeong Lee; Mee Joo Kang; Sun-Whe Kim
Journal:  Surg Endosc       Date:  2013-03-07       Impact factor: 4.584

5.  Antisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundus.

Authors:  J M Dick; W Van Molle; C Libert; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

6.  Time course analysis of cardiac pacing-induced gene expression changes in the canine heart.

Authors:  Mária Kovács; Márton Gönczi; Edina Kovács; Agnes Végh
Journal:  Mol Cell Biochem       Date:  2012-09-27       Impact factor: 3.396

Review 7.  PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer.

Authors:  Anindita Das; David Durrant; Fadi N Salloum; Lei Xi; Rakesh C Kukreja
Journal:  Pharmacol Ther       Date:  2014-10-31       Impact factor: 12.310

8.  Evidence against a role of inducible nitric oxide synthase in the endothelial protective effects of delayed preconditioning.

Authors:  K Laude; V Richard; J P Henry; F Lallemand; C Thuillez
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

9.  Mechanism of cyclooxygenase-2 upregulation in late preconditioning.

Authors:  Yu-Ting Xuan; Yiru Guo; Yanqing Zhu; Hui Han; Robert Langenbach; Buddhadeb Dawn; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2003-05       Impact factor: 5.000

10.  Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1,074 mice.

Authors:  Yiru Guo; Michael P Flaherty; Wen-Jian Wu; Wei Tan; Xiaoping Zhu; Qianhong Li; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2012-08-03       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.